ConductScience.org, home

Paper41803255

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Chen GM and 36 others. Nat Biomed Eng, 2026. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer. Papers, record 41803255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41803255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.
PubMed
Journal
Nat Biomed Eng
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
3.72, provisional
iCite
Revised in PubMed
2026-08-25
PubMed

Authors37

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen GMGregory Mhttps://orcid.org/0000-0002-4083-5083
2Jain AAnkita
3Gering DTDavid T
4Satulovsky JJavier
5Datta SSarbani
6Lai PPeng
7Karar JJayashree
8Gonzalez VEVanessa E
9Alexander KKathleen
10Chew AAnne
11Jadlowsky JKJulie Khttps://orcid.org/0009-0005-5115-1321
12Ruella MMarcohttps://orcid.org/0000-0003-4301-5811
13Paruzzo LLucahttps://orcid.org/0000-0002-6505-0194
14Amses KRKevin R
15Rech AJAndrew J
16Stadtmauer EAEdward A
17Frey NVNoelle V
18Hexner EOElizabeth Ohttps://orcid.org/0000-0002-1125-4060
19Porter DLDavid L
20Cohen ADAdam Dhttps://orcid.org/0000-0003-0939-3843

Source PubMed

See all 37 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, Chimeric AntigenMajor topic
Immunotherapy, AdoptiveMajor topic
Biomarkers, TumorMajor topic
Hematologic NeoplasmsMajor topic
Humans
T-Lymphocytes
Flow Cytometry

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 CA214278NCI NIH HHSUnited StatesP01CA214278PubMedNIH RePORTER
P30 CA016520NCI NIH HHSUnited StatesP30CA016520PubMedNIH RePORTER
U01 AG066100NIA NIH HHSUnited StatesU01AG066100PubMedNIH RePORTER
Engineering Research Center for Cell Manufacturing TechnologiesNational Science Foundation (NSF)PubMedPubMed

Download CSV of grants

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125317870Chimeric antigen receptor T cells for sustained remissions in leukemia.N Engl J Med2014https://conductscience.org/library/papers/25317870PubMed
235058619AI in health and medicine.Nat Med2022https://conductscience.org/library/papers/35058619PubMed
341803255Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.Nat Biomed Eng2026https://conductscience.org/library/papers/41803255PubMed
411390513Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells.J Immunol2001https://conductscience.org/library/papers/11390513PubMed
533328120Clinical applications of continual learning machine learning.Lancet Digit Health2020https://conductscience.org/library/papers/33328120PubMed
629218881Data-driven advice for applying machine learning to bioinformatics problems.Pac Symp Biocomput2018https://conductscience.org/library/papers/29218881PubMed
731636098Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.Clin Cancer Res2020https://conductscience.org/library/papers/31636098PubMed
838057668Dictionary of immune responses to cytokines at single-cell resolution.Nature2024https://conductscience.org/library/papers/38057668PubMed
929226797Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.N Engl J Med2017https://conductscience.org/library/papers/29226797PubMed
1033596362Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy.N Engl J Med2021https://conductscience.org/library/papers/33596362PubMed
1129385370Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.N Engl J Med2018https://conductscience.org/library/papers/29385370PubMed
1234175021
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Lancet2021https://conductscience.org/library/papers/34175021PubMed
1316340423Interleukin-8.Crit Care Med2005https://conductscience.org/library/papers/16340423PubMed
1426738796Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies.Sci Transl Med2016https://conductscience.org/library/papers/26738796PubMed
1523825369mRMRe: an R package for parallelized mRMR ensemble feature selection.Bioinformatics2013https://conductscience.org/library/papers/23825369PubMed
1619358741flowCore: a Bioconductor package for high throughput flow cytometry.BMC Bioinformatics2009https://conductscience.org/library/papers/19358741PubMed
1712563297Interleukin-12 and the regulation of innate resistance and adaptive immunity.Nat Rev Immunol2003https://conductscience.org/library/papers/12563297PubMed
1832298202Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia.J Clin Oncol2020https://conductscience.org/library/papers/32298202PubMed
1935110735Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.Nature2022https://conductscience.org/library/papers/35110735PubMed
2027586051The parameter sensitivity of random forests.BMC Bioinformatics2016https://conductscience.org/library/papers/27586051PubMed

See all 56 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42966861Prognostic scores and biomarkers in hematologic malignancies: current evidence and future perspectives.Biomark Res2026https://conductscience.org/library/papers/42966861PubMed
42919964Determinants of response to CAR T cell therapy in a multicenter, multi-trial cohort analysis of patients with lymphoma.Nat Med2026https://conductscience.org/library/papers/42919964PubMed
42909370mRNA-dendritic cell antigen vaccine potentiates CD38 CAR-T Cell therapy for relapsed/refractory acute myeloid leukemia.Theranostics2026https://conductscience.org/library/papers/42909370PubMed
42819351CAR T cell cancer immunotherapy: who does the job?Front Immunol2026https://conductscience.org/library/papers/42819351PubMed
42713305AI and authorship: Norms and uses to preserve human-led science.PNAS Nexus2026https://conductscience.org/library/papers/42713305PubMed
42681680A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.J Hematol Oncol2026https://conductscience.org/library/papers/42681680PubMed
42480604Development of tandem canine CAR T cells to enable comparative studies of aggressive B-cell lymphoma.Mol Cancer Ther2026https://conductscience.org/library/papers/42480604PubMed
42198346Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42198346PubMed
42122207Determinants of Chimeric Antigen Receptor (CAR) T Cell Success: In Vitro and In Vivo Preclinical Assessment.Cancers (Basel)2026https://conductscience.org/library/papers/42122207PubMed
42088834Remodeling memory T cells with chemotherapy and immune checkpoint inhibitors as host pre-conditioning to empower in vivo CAR-T therapy.Synth Syst Biotechnol2026https://conductscience.org/library/papers/42088834PubMed
41803255Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.Nat Biomed Eng2026https://conductscience.org/library/papers/41803255PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41803255

GET https://conductscience.org/api/papers/v1/41803255/authors?page=2